MedTech In GCC Region After COVID-19: An Introduction


The first peak of COVID-19 was documented on July 19, 2020, where around 14.3 million people were affected by the pandemic worldwide. The GCC region saw a total of 0.57 million reported COVID-19 cases on that very same day. 

To mitigate any further spreading of COVID-19 in the GCC nations, the governments initiated the promotion of the MedTech industry in the form of in-vitro diagnostic kits, smart AI medical devices, ventilators, and surgical masks, among others. Additionally, smart robots were launched to curb COVID-19. The UAE set up virtual hospitals while Saudi Arabia launched GHAD (a Unified Electronic Platform).


These and many other drastic measures brought the pandemic in the GCC nations under control. The total number of COVID-19 cases in the GCC nations fell from 4.03% to 1.05% of the global COVID-19 cases by October 11, 2021. 


As of now, government bodies and regulators in the GCC nations have taken additional steps to improve the MedTech industry. These include improvisation of registration processes, import, procurement, and liberalizing restrictions on PPEs and kits. Certain devices are now recognized as National Security Devices, thus helping to achieve regional self-sufficiency in the wake of the ongoing pandemic.


The government initiatives takes to support the MedTech industry in GCC nations is are as follow:

  • The launch of social infrastructure projects.

  • Introduction of AI-associated medical devices and smart monitors.

  • Adopting wearable devices among patients.

  • Providing access to COVID-19 combating devices.

  • Easing government guidelines related to medical devices.

  • Introducing innovative electronic platforms.


Steps taken by Key MedTech Players to combat COVID-19 in the GCC region, include:

  • Increased investments in emerging medical technologies.

  • Geographical diversification.

  • Optimization in supply chains.


COVID-19 has a massive impact on the MedTech industry in the GCC region. Various strategies were undertaken by the GCC governments that overall improved the MedTech industry. A prominent difference was witnessed after COVID-19 because of the many crucial technological introductions made by the medical device manufacturers.


The governments are also increasing their spendings on healthcare, thus making the GCC region a lucrative market for medical device manufacturers. 


Source: MedTech Industry in GCC post-Covid-19 - DUPHAT.

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more

Test

  Partial Seizure Market | Parkinson's Disease Levodopa-Induced Dyskinesia Market | Metabolic Acidosis Market | Hepatitis D Market | Gaucher's disease Market | Gastric Neuroendocrine Tumours Market | Familial Chylomicronemia Syndrome Market | Exocrine Pancreatic Insufficiency Market | Crohn's Disease Market | Contact Dermatitis Market | Concussions Market Size | Chronic Bronchitis Market | Chondrosarcoma Market | Palmar Hyperhidrosis Market | Hpv Induced Cancers Market | Alstrom Syndrome Market | Astigmatism Market | Meningioma Market | Central Retinal Vein Occlusion Market | Intracranial Pressure Monitoring Devices Market | Head And Neck Squamous Cell Carcinoma Market | Hyperopia Market | Thyroid Eye Disease Market | Rett Syndrome Market | Cipn Market | Chemotherapy Induced Peripheral Neuropathy Market | Idiopathic Membranous Nephropathy Market | Walking Impairment In Multiple Sclerosis Market  |  Triple Negative Breast Cancer Market  | Sjogren&#
Read more